4.37
price down icon0.46%   -0.02
after-market 시간 외 거래: 4.37
loading
전일 마감가:
$4.39
열려 있는:
$4.4
하루 거래량:
30,397
Relative Volume:
0.48
시가총액:
$83.39M
수익:
-
순이익/손실:
$-34.17M
주가수익비율:
-1.9306
EPS:
-2.2635
순현금흐름:
$-47.63M
1주 성능:
+4.80%
1개월 성능:
+2.34%
6개월 성능:
+26.67%
1년 성능:
+51.21%
1일 변동 폭
Value
$4.2417
$4.44
1주일 범위
Value
$4.08
$4.685
52주 변동 폭
Value
$2.30
$5.12

폴리피드 Stock (PYPD) Company Profile

Name
명칭
Polypid Ltd
Name
전화
-
Name
주소
-
Name
직원
75
Name
트위터
Name
다음 수익 날짜
2024-11-13
Name
최신 SEC 제출 서류
Name
PYPD's Discussions on Twitter

Compare PYPD vs VRTX, REGN, ARGX, ALNY, ONC

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PYPD
Polypid Ltd
4.37 83.78M 0 -34.17M -47.63M -2.2635
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
458.05 114.72B 12.07B 3.95B 3.19B 15.33
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
737.45 78.67B 14.34B 4.50B 3.77B 41.56
Biotechnology icon
ARGX
Argen X Se Adr
684.50 42.38B 4.16B 1.29B 734.26M 19.59
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
311.10 41.75B 3.71B 313.75M 465.38M 2.2571
Biotechnology icon
ONC
Beone Medicines Ltd Adr
282.72 31.33B 5.36B 287.73M 924.18M 2.5229

폴리피드 Stock (PYPD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-05 개시 Roth Capital Buy
2025-06-02 재개 H.C. Wainwright Buy
2025-01-28 개시 Rodman & Renshaw Buy
2021-09-14 개시 JMP Securities Mkt Outperform
2021-07-30 개시 Cantor Fitzgerald Overweight
2020-11-24 업그레이드 Raymond James Outperform → Strong Buy
2020-08-10 개시 Alliance Global Partners Buy
2020-07-21 개시 BMO Capital Markets Outperform
2020-07-21 개시 Barclays Overweight
2020-07-21 개시 Raymond James Outperform
모두보기

폴리피드 주식(PYPD)의 최신 뉴스

pulisher
02:33 AM

PolyPid Ltd. (NASDAQ:PYPD) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

02:33 AM
pulisher
Mar 18, 2026

PolyPid (PYPD) director discloses stock options on 17,456 shares - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

PolyPid (PYPD) director details shares and vested stock options - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

PolyPid (PYPD) CEO details stock and option holdings in Form 3 - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

PolyPid (PYPD) deputy CEO discloses extensive employee stock options - Stock Titan

Mar 18, 2026
pulisher
Mar 18, 2026

PolyPid Ltd. (NASDAQ:PYPD) Q4 2025 earnings call transcript - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

PolyPid Approaches NDA Submission as New Medicare Model Creates Strong Incentives for SSI Prevention - TipRanks

Mar 18, 2026
pulisher
Mar 17, 2026

Is PolyPid Ltd likely to announce a buybackEarnings Growth Report & Step-by-Step Trade Execution Guides - baoquankhu1.vn

Mar 17, 2026
pulisher
Mar 17, 2026

PolyPid granted $4.3M waiver from FDA for D-Plex application - TipRanks

Mar 17, 2026
pulisher
Mar 17, 2026

PolyPid receives $4.3M FDA fee waiver for D-PLEX100 application - Investing.com

Mar 17, 2026
pulisher
Mar 17, 2026

Polypid receives PDUFA fee waiver from FDA for D-Plex100's new drug application - marketscreener.com

Mar 17, 2026
pulisher
Mar 17, 2026

$4.3M FDA fee waived for new drug to prevent surgical infections - Stock Titan

Mar 17, 2026
pulisher
Mar 15, 2026

PolyPid Ltd. (NASDAQ:PYPD) Sees Large Drop in Short Interest - MarketBeat

Mar 15, 2026
pulisher
Mar 15, 2026

PolyPid Ltd Stock (ISIN: US70450B1035) Surges on Analyst Optimism: 260% Upside Forecast Signals Majo - AD HOC NEWS

Mar 15, 2026
pulisher
Mar 14, 2026

Wall Street Zen Upgrades PolyPid (NASDAQ:PYPD) to Hold - MarketBeat

Mar 14, 2026
pulisher
Mar 10, 2026

PolyPid at Citizens Life Sciences: Strategic Moves and Market Expansion - Investing.com India

Mar 10, 2026
pulisher
Mar 10, 2026

PolyPid at Citizens Life Sciences: Strategic Moves and Market Expansion By Investing.com - Investing.com Australia

Mar 10, 2026
pulisher
Mar 10, 2026

PYPD: NDA submission for D-PLEX₁₀₀ is imminent, backed by strong Phase 3 efficacy data - TradingView

Mar 10, 2026
pulisher
Mar 07, 2026

How PolyPid Ltd. stock performs in stagflation2026 Short Interest & Stepwise Trade Execution Plans - Naître et grandir

Mar 07, 2026
pulisher
Mar 03, 2026

PYPD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026
pulisher
Feb 28, 2026

PolyPid (NASDAQ:PYPD) Downgraded by Wall Street Zen to "Sell" - MarketBeat

Feb 28, 2026
pulisher
Feb 27, 2026

PYPD PE Ratio & Valuation, Is PYPD Overvalued - Intellectia AI

Feb 27, 2026
pulisher
Feb 25, 2026

PolyPid Announces Participation in Upcoming Investor Conferences - Bitget

Feb 25, 2026
pulisher
Feb 24, 2026

PolyPid Ltd. Auditor Raises 'Going Concern' Doubt - marketscreener.com

Feb 24, 2026
pulisher
Feb 22, 2026

PolyPid Ltd. (NASDAQ:PYPD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat

Feb 22, 2026
pulisher
Feb 20, 2026

Is PolyPid Ltd. stock forming a triangle patternJuly 2025 Recap & Daily Profit Maximizing Trade Tips - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Does PolyPid Ltd. have high return on assetsMarket Sentiment Report & Long-Term Growth Portfolio Plans - mfd.ru

Feb 19, 2026
pulisher
Feb 18, 2026

Is PolyPid Ltd. stock technically oversoldJuly 2025 Analyst Calls & Weekly Top Gainers Trade List - mfd.ru

Feb 18, 2026
pulisher
Feb 17, 2026

PYPD SEC FilingsPolypid Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Polypid targets rolling NDA submission for D-PLEX100 by end of Q1 2026 amid advanced US partnership talks - MSN

Feb 16, 2026
pulisher
Feb 15, 2026

Aug Decliners: Is PolyPid Ltd likely to announce a buyback2025 Technical Patterns & Fast Gain Swing Trade Alerts - baoquankhu1.vn

Feb 15, 2026
pulisher
Feb 15, 2026

PolyPid Ltd. (NASDAQ:PYPD) Short Interest Up 44.8% in January - MarketBeat

Feb 15, 2026
pulisher
Feb 14, 2026

Research Analysts Issue Forecasts for PolyPid Q1 Earnings - Defense World

Feb 14, 2026
pulisher
Feb 13, 2026

HC Wainwright Predicts PolyPid's Q1 Earnings (NASDAQ:PYPD) - MarketBeat

Feb 13, 2026
pulisher
Feb 13, 2026

When Will PolyPid Ltd. (NASDAQ:PYPD) Turn A Profit? - Yahoo Finance

Feb 13, 2026
pulisher
Feb 13, 2026

PolyPid Q4 Earnings Call Highlights - Defense World

Feb 13, 2026
pulisher
Feb 12, 2026

PolyPid Ltd. (NASDAQ:PYPD) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 12, 2026
pulisher
Feb 12, 2026

Is PolyPid Ltd. likely to announce a buybackJuly 2025 Recap & Low Risk High Win Rate Picks - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

FY2028 Earnings Forecast for PolyPid Issued By HC Wainwright - MarketBeat

Feb 12, 2026
pulisher
Feb 12, 2026

PolyPid Earnings Call Flags Big 2026 Catalyst - The Globe and Mail

Feb 12, 2026
pulisher
Feb 11, 2026

PolyPid (PYPD) Analyst Rating Reiteration by HC Wainwright | PYP - GuruFocus

Feb 11, 2026
pulisher
Feb 11, 2026

PolyPid (NASDAQ:PYPD) Earns Buy Rating from HC Wainwright - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

PolyPid (NASDAQ:PYPD) Releases Earnings Results, Misses Expectations By $0.07 EPS - MarketBeat

Feb 11, 2026
pulisher
Feb 11, 2026

Earnings call transcript: PolyPid’s Q4 2025 results miss EPS forecasts By Investing.com - Investing.com Australia

Feb 11, 2026
pulisher
Feb 11, 2026

Earnings call transcript: PolyPid’s Q4 2025 results miss EPS forecasts - Investing.com India

Feb 11, 2026
pulisher
Feb 11, 2026

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results - The Manila Times

Feb 11, 2026
pulisher
Feb 11, 2026

PolyPid Ltd. Advances U.S. Partnership Talks for D-PLEX₁₀₀ Following Positive FDA Feedback and Plans Rolling NDA Review - Quiver Quantitative

Feb 11, 2026
pulisher
Feb 11, 2026

PolyPid (PYPD) deepens 2025 loss while D-PLEX100 advances toward FDA NDA filing - Stock Titan

Feb 11, 2026
pulisher
Feb 11, 2026

PolyPid (PYPD) Q4 2025 Earnings Call Transcript - The Globe and Mail

Feb 11, 2026
pulisher
Feb 10, 2026

Preview: PolyPid's Earnings - Benzinga

Feb 10, 2026
pulisher
Feb 09, 2026

Will PolyPid Ltd. stock recover after earnings2025 AllTime Highs & Capital Protection Trade Alerts - mfd.ru

Feb 09, 2026

폴리피드 (PYPD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$99.29
price up icon 1.20%
$27.80
price up icon 0.00%
$52.37
price down icon 0.06%
$89.31
price down icon 0.77%
$144.00
price up icon 0.91%
biotechnology ONC
$282.72
price up icon 0.15%
자본화:     |  볼륨(24시간):